A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis

INTRODUCTION: Natalizumab is a new humanized monoclonal antibody used in multiple sclerosis (MS). The aim of this meta-analysis was to evaluate the efficacy and tolerability of this drug in relapsing MS. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikfar, Shekoufeh, Rahimi, Roja, Rezaie, Ali, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281346/
https://www.ncbi.nlm.nih.gov/pubmed/22371753
http://dx.doi.org/10.5114/aoms.2010.13901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281346/
https://www.ncbi.nlm.nih.gov/pubmed/22371753
http://dx.doi.org/10.5114/aoms.2010.13901

Ejemplares similares